title: A soluble factor(s) released by MRC-5 cells early and late after human cytomegalovirus infection induces maturation of monocyte-derived dendritic cells.
abstract: A human cytomegalovirus (HCMV) strain passaged 10 times on MRC-5 human fibroblast cells failed to express immediate early (IE) antigens in immature dendritic cells (iDCs) after infection. However, both the early and the late HCMV conditioning medium, harvested from MRC-5 cells at 24 h or 7-9 days after infection, respectively, induced a higher ratio of DCs expressing maturation markers (CD40, CD83, CD86 and HLA-DR) on the surface of the cells. HCMV conditioning medium, ultracentrifuged to remove virus particles, exhibited a similarly enhanced expression of DC maturation markers. DCs treated with HCMV conditioning medium harvested late after infection increased the percentages of autologous CD4+ and CD8+ cells of seropositive donors to produce IFN-gamma and stimulated HCMV-specific lymphoproliferative responses. The early HCMC conditioning medium was also able to induce the functional maturation of DCs, as demonstrated by supplementing this medium with a Chlamydia pneumoniae antigen.
authors.affiliation: Division of Virology, National Center for Epidemiology, Budapest, Hungary.
authors.forename: Z
authors.initials: Z
authors.lastname: Kis
authors.forename: E
authors.initials: E
authors.lastname: Pallinger
authors.forename: V
authors.initials: V
authors.lastname: Endresz
authors.forename: K
authors.initials: K
authors.lastname: Burian
authors.forename: A
authors.initials: A
authors.lastname: Falus
authors.forename: G
authors.initials: G
authors.lastname: Berencsi
authors.forename: E
authors.initials: E
authors.lastname: Gonczol
mesh_terms: D051940:B7-2 Antigen / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D019013:CD40 Antigens / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002454:Cell Differentiation; D002478:Cells, Cultured; D017077:Culture Media, Conditioned / Q000494:pharmacology*; D003587:Cytomegalovirus / Q000472:pathogenicity*; D003586:Cytomegalovirus Infections / Q000821:virology; D003713:Dendritic Cells / Q000166:cytology* / Q000187:drug effects / Q000276:immunology; D005347:Fibroblasts / Q000378:metabolism* / Q000821:virology; D006684:HLA-DR Antigens / Q000378:metabolism; D006801:Humans; D008213:Lymphocyte Activation; D009000:Monocytes / Q000166:cytology* / Q000187:drug effects; D012995:Solubility
chemical_list: D051940:B7-2 Antigen; D019013:CD40 Antigens; D017077:Culture Media, Conditioned; D006684:HLA-DR Antigens